Loading...
Derniers dépôts
-
Giuseppe Orlando, Richard Danger, Hayrettin Okut, Lauren Edgar, Benedetta Bussolati, et al.. Molecular Pathways Underlying Adaptive Repair of the Injured Kidney: Novel Donation After Cardiac Death and Acute Kidney Injury Platforms. Annals of Surgery, 2019, 271 (2), pp.383-390. ⟨10.1097/SLA.0000000000002946⟩. ⟨inserm-02157643⟩
-
Benjamin Gaborit, Eric Dailly, Bernard Vanhove, Régis Josien, Karine Lacombe, et al.. Pharmacokinetics and Safety of XAV-19, a Swine Glyco-humanized Polyclonal Anti-SARS-CoV-2 Antibody, for COVID-19-Related Moderate Pneumonia: a Randomized, Double-Blind, Placebo-Controlled, Phase IIa Study. Antimicrobial Agents and Chemotherapy, 2021, 65 (9), ⟨10.1128/AAC.01237-21⟩. ⟨hal-03378960⟩
-
Marwan Bouras, Philippe Tessier, Cécile Poulain, Solène Schirr-Bonnans, Antoine Roquilly. Three-month outcomes and cost-effectiveness of interferon gamma-1b in critically ill patients: a secondary analysis of the PREV-HAP trial. Journal of Intensive Care, 2024, 12 (1), pp.40. ⟨10.1186/s40560-024-00753-z⟩. ⟨inserm-04797601⟩
-
Antoine Roquilly, Bruno Francois, Olivier Huet, Yoann Launey, Sigismond Lasocki, et al.. Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial. Intensive Care Medicine, 2023, 49 (5), pp.530-544. ⟨10.1007/s00134-023-07065-0⟩. ⟨hal-04769433⟩
Nombre de documents
955
Nombre de notices
442
RECHERCHE
widget_sherpa